Product Images Edarbi

This is a population description for a study, including criteria for age, gender, race, and various impairments. It indicates whether or not dose adjustments are recommended based on fold changes and 90% CI, and notes when there is no experience with certain groups.*

This is a blood pressure monitoring study with readings for both diastolic and systolic pressure. The readings are given in mm Hg units. The study involved four groups: Edarbi80mg, Placebo, Olmesartan 40 mg, and Valsartan 320mg. The results are presented at different hours postdose.*

NDC 60631-040-30 is a prescription medication known as Ayedarbi, containing azisartan medoxomil. Each container has 30 white tablets, and the typical dose is outlined in the package insert. The medication should be stored at room temperature, between 15-30°C, in its original container, protected from moisture and light. This medication is manufactured in Ireland by Arbor.*

This is a description of medication with the trade name "edarbi" which is available in tablet form. The tablets are packaged in bottles containing 30 tablets each. The package insert should be consulted for the usual dosage. The active ingredient in each white tablet is 85.36 mg azilsartan kamedoxomil, which is equivalent to 80 mg azilsartan medoxomil. The medication should be stored at room temperature with excursions allowed between 15-30°C (59-86°F) and protected from moisture and light. The medication is manufactured in Ireland and should not be repackaged or removed from the original container. The label contains a barcode and a serial number.*